SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Allscripts Healthcare Solutions, Inc. – ‘10-Q’ for 6/30/13 – ‘EX-10.16’

On:  Friday, 8/9/13, at 4:02pm ET   ·   For:  6/30/13   ·   Accession #:  1193125-13-329137   ·   File #:  1-35547

Previous ‘10-Q’:  ‘10-Q’ on 5/10/13 for 3/31/13   ·   Next:  ‘10-Q’ on 11/12/13 for 9/30/13   ·   Latest:  ‘10-Q’ on 11/7/22 for 9/30/22   ·   3 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 8/09/13  Allscripts Healthcare Soluti… Inc 10-Q        6/30/13  133:11M                                    Donnelley … Solutions/FA

Quarterly Report   —   Form 10-Q   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    831K 
 2: EX-10.16    Material Contract                                   HTML     54K 
 3: EX-10.17    Material Contract                                   HTML     40K 
 4: EX-31.1     Certification -- §302 - SOA'02                      HTML     40K 
 5: EX-31.2     Certification -- §302 - SOA'02                      HTML     40K 
 6: EX-32.1     Certification -- §906 - SOA'02                      HTML     35K 
130: R1          Document and Entity Information                     HTML     56K  
79: R2          Consolidated Balance Sheets                         HTML    145K 
74: R3          Consolidated Balance Sheets (Parenthetical)         HTML     61K 
19: R4          Consolidated Statements of Operations               HTML     97K 
77: R5          Consolidated Statements of Comprehensive Income     HTML     69K 
                (Loss)                                                           
50: R6          Consolidated Statements of Cash Flows               HTML    135K 
107: R7          Consolidated Statements of Cash Flows               HTML     35K  
                (Parenthetical)                                                  
53: R8          Summary of Significant Accounting Policies          HTML     53K 
58: R9          Business Combinations                               HTML     77K 
20: R10         Fair Value Measurements                             HTML     71K 
55: R11         Stockholders' Equity                                HTML     87K 
106: R12         Earnings Per Share                                  HTML     68K  
100: R13         Goodwill and Intangible Assets                      HTML     85K  
75: R14         Debt                                                HTML    100K 
124: R15         Income Taxes                                        HTML     48K  
104: R16         Derivative Financial Instruments                    HTML     65K  
16: R17         Contingencies                                       HTML     55K 
24: R18         Business Segments                                   HTML     75K 
123: R19         North American Site Consolidation Plan              HTML     39K  
128: R20         Summary of Significant Accounting Policies          HTML     70K  
                (Policies)                                                       
132: R21         Summary of Significant Accounting Policies          HTML     40K  
                (Tables)                                                         
126: R22         Business Combinations (Tables)                      HTML     71K  
90: R23         Fair Value Measurements (Tables)                    HTML     61K 
21: R24         Stockholders' Equity (Tables)                       HTML     75K 
49: R25         Earnings Per Share (Tables)                         HTML     69K 
33: R26         Goodwill and Intangible Assets (Tables)             HTML     82K 
32: R27         Debt (Tables)                                       HTML     81K 
60: R28         Income Taxes (Tables)                               HTML     42K 
89: R29         Derivative Financial Instruments (Tables)           HTML     48K 
102: R30         Business Segments (Tables)                          HTML     68K  
41: R31         Amounts Reclassified (Detail)                       HTML     36K 
61: R32         Business Combinations - Additional Information      HTML    109K 
                (Detail)                                                         
115: R33         Fair Value of Consideration Transferred for         HTML     47K  
                Acquisition (Detail)                                             
36: R34         Fair Value of Consideration Transferred for         HTML     45K 
                Acquisition (Parenthetical) (Detail)                             
97: R35         Assets Acquired and Liabilities Assumed (Detail)    HTML     63K 
98: R36         Acquired Intangible Assets Amortization (Detail)    HTML     43K 
64: R37         Proforma Results (Detail)                           HTML     52K 
31: R38         Summary of Financial Assets and Liabilities         HTML     68K 
                Measured at Fair Value on Recurring Basis (Detail)               
94: R39         Fair Value Measurements - Additional Information    HTML     61K 
                (Detail)                                                         
39: R40         Weighted Average Input Assumptions (Detail)         HTML     47K 
59: R41         Stock-Based Compensation Expense (Detail)           HTML     58K 
103: R42         Stock-Based Awards Granted (Detail)                 HTML     50K  
46: R43         Stockholders' Equity - Additional Information       HTML     97K 
                (Detail)                                                         
91: R44         Calculations of Earnings Per Share (Detail)         HTML     64K 
73: R45         Anti-Dilutive Stock Options, Restricted Stock Unit  HTML     39K 
                Awards and Warrants Excluded from Computation of                 
                Diluted (Loss) Earnings Per Share (Detail)                       
35: R46         Goodwill and Intangible Assets (Detail)             HTML     52K 
111: R47         Goodwill and Intangible Assets - Additional         HTML     43K  
                Information (Detail)                                             
29: R48         Changes in Carrying Amount of Goodwill (Detail)     HTML     75K 
40: R49         Debt Outstanding (Detail)                           HTML     49K 
72: R50         Interest Expense (Detail)                           HTML     49K 
83: R51         Debt - Additional Information (Detail)              HTML    201K 
109: R52         Summary of Future Payments under Notes and Senior   HTML     65K  
                Secured Credit Facilities (Detail)                               
17: R53         Effective Tax Rates (Detail)                        HTML     44K 
93: R54         Income Taxes - Additional Information (Detail)      HTML     41K 
66: R55         Derivative Financial Instruments - Additional       HTML     88K 
                Information (Detail)                                             
23: R56         Activity Related to Interest Rate Swap Agreement    HTML     49K 
                (Detail)                                                         
30: R57         Contingencies - Additional Information (Detail)     HTML     47K 
78: R58         Revenues and Income from Operations Related to      HTML     50K 
                Segment Within Reconciliation to Consolidated                    
                Amounts (Detail)                                                 
118: R59         North American Site Consolidation Plan -            HTML     55K  
                Additional Information (Detail)                                  
70: XML         IDEA XML File -- Filing Summary                      XML    140K 
133: XML.R1      Document and Entity Information                      XML    143K  
57: XML.R2      Consolidated Balance Sheets                          XML    375K 
88: XML.R3      Consolidated Balance Sheets (Parenthetical)          XML    149K 
69: XML.R4      Consolidated Statements of Operations                XML    466K 
65: XML.R5      Consolidated Statements of Comprehensive Income      XML    212K 
                (Loss)                                                           
14: XML.R6      Consolidated Statements of Cash Flows                XML    396K 
81: XML.R7      Consolidated Statements of Cash Flows                XML     74K 
                (Parenthetical)                                                  
13: XML.R8      Summary of Significant Accounting Policies           XML     68K 
45: XML.R9      Business Combinations                                XML    100K 
63: XML.R10     Fair Value Measurements                              XML     91K 
54: XML.R11     Stockholders' Equity                                 XML    107K 
47: XML.R12     Earnings Per Share                                   XML     92K 
112: XML.R13     Goodwill and Intangible Assets                       XML    112K  
56: XML.R14     Debt                                                 XML    126K 
127: XML.R15     Income Taxes                                         XML     64K  
85: XML.R16     Derivative Financial Instruments                     XML     79K 
82: XML.R17     Contingencies                                        XML     64K 
87: XML.R18     Business Segments                                    XML     97K 
38: XML.R19     North American Site Consolidation Plan               XML     53K 
76: XML.R20     Summary of Significant Accounting Policies           XML    109K 
                (Policies)                                                       
101: XML.R21     Summary of Significant Accounting Policies           XML     56K  
                (Tables)                                                         
105: XML.R22     Business Combinations (Tables)                       XML    107K  
114: XML.R23     Fair Value Measurements (Tables)                     XML     83K  
62: XML.R24     Stockholders' Equity (Tables)                        XML    108K 
28: XML.R25     Earnings Per Share (Tables)                          XML     97K 
121: XML.R26     Goodwill and Intangible Assets (Tables)              XML    114K  
86: XML.R27     Debt (Tables)                                        XML    118K 
122: XML.R28     Income Taxes (Tables)                                XML     59K  
22: XML.R29     Derivative Financial Instruments (Tables)            XML     66K 
99: XML.R30     Business Segments (Tables)                           XML     91K 
96: XML.R31     Amounts Reclassified (Detail)                        XML     81K 
27: XML.R32     Business Combinations - Additional Information       XML    773K 
                (Detail)                                                         
125: XML.R33     Fair Value of Consideration Transferred for          XML    103K  
                Acquisition (Detail)                                             
25: XML.R34     Fair Value of Consideration Transferred for          XML    121K 
                Acquisition (Parenthetical) (Detail)                             
129: XML.R35     Assets Acquired and Liabilities Assumed (Detail)     XML    188K  
116: XML.R36     Acquired Intangible Assets Amortization (Detail)     XML    234K  
110: XML.R37     Proforma Results (Detail)                            XML    243K  
113: XML.R38     Summary of Financial Assets and Liabilities          XML    878K  
                Measured at Fair Value on Recurring Basis (Detail)               
68: XML.R39     Fair Value Measurements - Additional Information     XML    240K 
                (Detail)                                                         
51: XML.R40     Weighted Average Input Assumptions (Detail)          XML    101K 
131: XML.R41     Stock-Based Compensation Expense (Detail)            XML    286K  
95: XML.R42     Stock-Based Awards Granted (Detail)                  XML    270K 
120: XML.R43     Stockholders' Equity - Additional Information        XML    764K  
                (Detail)                                                         
26: XML.R44     Calculations of Earnings Per Share (Detail)          XML    219K 
84: XML.R45     Anti-Dilutive Stock Options, Restricted Stock Unit   XML     81K 
                Awards and Warrants Excluded from Computation of                 
                Diluted (Loss) Earnings Per Share (Detail)                       
48: XML.R46     Goodwill and Intangible Assets (Detail)              XML    214K 
80: XML.R47     Goodwill and Intangible Assets - Additional          XML    131K 
                Information (Detail)                                             
71: XML.R48     Changes in Carrying Amount of Goodwill (Detail)      XML   1.02M 
42: XML.R49     Debt Outstanding (Detail)                            XML    289K 
92: XML.R50     Interest Expense (Detail)                            XML    134K 
43: XML.R51     Debt - Additional Information (Detail)               XML   3.45M 
52: XML.R52     Summary of Future Payments under Notes and Senior    XML    493K 
                Secured Credit Facilities (Detail)                               
15: XML.R53     Effective Tax Rates (Detail)                         XML    113K 
108: XML.R54     Income Taxes - Additional Information (Detail)       XML     92K  
117: XML.R55     Derivative Financial Instruments - Additional        XML    900K  
                Information (Detail)                                             
34: XML.R56     Activity Related to Interest Rate Swap Agreement     XML    134K 
                (Detail)                                                         
37: XML.R57     Contingencies - Additional Information (Detail)      XML    132K 
18: XML.R58     Revenues and Income from Operations Related to       XML    530K 
                Segment Within Reconciliation to Consolidated                    
                Amounts (Detail)                                                 
119: XML.R59     North American Site Consolidation Plan -             XML    276K  
                Additional Information (Detail)                                  
67: EXCEL       IDEA Workbook of Financial Reports (.xls)            XLS   1.03M 
 7: EX-101.INS  XBRL Instance -- mdrx-20130630                       XML   1.67M 
 9: EX-101.CAL  XBRL Calculations -- mdrx-20130630_cal               XML    226K 
10: EX-101.DEF  XBRL Definitions -- mdrx-20130630_def                XML    640K 
11: EX-101.LAB  XBRL Labels -- mdrx-20130630_lab                     XML   1.32M 
12: EX-101.PRE  XBRL Presentations -- mdrx-20130630_pre              XML    924K 
 8: EX-101.SCH  XBRL Schema -- mdrx-20130630                         XSD    198K 
44: ZIP         XBRL Zipped Folder -- 0001193125-13-329137-xbrl      Zip    172K 


‘EX-10.16’   —   Material Contract


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



  EX-10.16  

Exhibit 10.16

AMENDED AND RESTATED

ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.

DIRECTOR DEFERRED COMPENSATION PLAN

1. Purpose. The purpose of the Allscripts Healthcare Solutions, Inc. Director Deferred Compensation Plan is to provide members of the Board of Directors of Allscripts Healthcare Solutions, Inc. (the “Company”) who are not employees of the Company or its subsidiaries with the opportunity to elect to defer all or a portion of (i) the cash retainer fees otherwise payable to them by the Company into deferred stock units and (ii) the restricted stock units granted to them by the Company.

2. Definitions. For purposes of the Plan:

(a) “Account” means the separate account maintained on the books of the Company for each Participant pursuant to Section 7, consisting of the Cash Retainer Sub-Account and the RSU Sub-Account.

(b) “Board” means the Board of Directors of the Company.

(c) “Committee” means the Compensation Committee of the Board.

(d) “Common Stock” means the common stock of the Company.

(e) “Deferred Stock Units” means deferred stock units credited to a Participant’s Account pursuant to elections by the Participant under Sections 5 and 6.

(f) “Director” means any member of the Board who is not an employee of the Company or any of its subsidiaries.

(g) “Disabled” means a Director is unable to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment that can be expected to result in death or can be expected to last for a continuous period of not less than 12 months.

(h) “Effective Date” means December 23, 2010.

(i) “Fair Market Value” means as of any date the closing price of the Common Stock as reported on the NASDAQ Global Select Market for that date or, if no closing price is reported for that date, the closing price on the next preceding date for which a closing price is reported, unless otherwise determined by the Committee.

(j) “Participant” means a Director who makes a deferral election under Section 5 or 6 of the Plan.

(k) “Plan” means the Allscripts Healthcare Solutions, Inc. Director Deferred Compensation Plan as set forth herein and as amended from time to time.

(l) “Restricted Stock Units” or “RSUs” means restricted stock units granted to the Participant under the Stock Plan.

(m) “Section 409A” means Section 409A of the Internal Revenue Code of 1986, as amended.


(n) “Stock Plan” means the Allscripts Healthcare Solutions, Inc. 2011 Stock Incentive Plan as amended from time to time.

3. Administration. The Plan shall be administered by the Committee. The Committee shall, subject to the terms of this Plan, interpret this Plan and the application thereof and establish, amend and revoke rules and regulations as it deems necessary or desirable for the administration of the Plan. All such interpretations, rules, regulations and conditions shall be final, binding and conclusive upon the Participants and all other persons having or claiming any right or interest in the Plan or the Deferred Stock Units.

A majority of the Committee shall constitute a quorum. The Committee shall take action either by (i) a majority of the members of the Committee present at any meeting at which a quorum is present or (ii) written approval by all of the members of the Committee without a meeting. The Committee may authorize any one or more of its number or any officer of the Company to execute and deliver documents on behalf of the Committee.

No member of the Board or the Committee, and no officer of the Company to whom the Committee delegates any of its power and authority hereunder, shall be liable for any act, omission, interpretation, construction or determination made in connection with this Plan in good faith; and the members of the Board, the Committee and such officers shall be entitled to indemnification and reimbursement by the Company in respect of any claim, loss, damage or expense (including attorneys’ fees) arising therefrom to the full extent permitted by law.

4. Eligibility. Each Director shall be eligible to participate in the Plan and to make the elections provided under Sections 5 and 6.

5. Deferral of Cash Retainer.

(a) Annual Elections. Prior to the first day of each calendar year beginning on or after January 1, 2011, each Director may elect to defer payment of all or a portion of the Director’s cash retainer fees to be earned in such calendar year that will be credited to the Cash Retainer Sub-Account of the Participant’s Account. Any election made under this paragraph shall become irrevocable as of December 31 of the year prior to the year in which the services relating to the cash retainer fee are performed.

(b) Initial Participant Elections. An individual who becomes a Director for the first time after a calendar year has commenced may make a deferral election, not later than the 30th day following the date the individual becomes a Director, with respect to all or a portion of the Director’s annual cash retainer that is earned for calendar quarters that begin after the date of such election that will credited to the Cash Retainer Sub-Account of the Participant’s Account.

(c) Effect of Elections. Any election made pursuant to this Section shall remain in effect for future calendar years unless and until the Participant makes a new election in accordance with Section 5(a). In order to change the amount of a deferral for any subsequent calendar year (or to cease deferrals), a Participant must make a new election prior to the calendar year for which the new election is to be effective.

 

2


6. Deferral of Restricted Stock Units.

(a) Annual Elections. Prior to the first day of each calendar year beginning on or after January 1, 2011, each Director may elect, in accordance with rules and procedures established by the Committee, to defer payment of all or a portion of the Restricted Stock Units granted to the Director in such calendar year that will be credited to the RSU Sub-Account of the Participant’s Account. Any election made under this paragraph shall become irrevocable as of December 31 of the year prior to the year in which the RSUs relating to the election are granted.

(b) Initial Participant Elections. An individual who becomes a Director for the first time after a calendar year has commenced may make a deferral election, not later than the earlier of (i) the 30th day following the date the individual becomes a Director and (ii) the day prior to the grant of Restricted Stock Units in such calendar year to the Director, with respect to all or a portion of the RSUs granted to the Director in such calendar year that will credited to the RSU Sub-Account of the Participant’s Account.

(c) Effect of Elections. Any election made pursuant to this Section shall remain in effect for future calendar years unless and until the Participant makes a new election in accordance with Section 6(a). In order to change the number of Restricted Stock Units deferred for any subsequent calendar year (or to cease deferrals), a Participant must make a new election prior to the calendar year for which the new election is to be effective.

7. Account.

(a) Cash Retainers. The crediting of Deferred Stock Units to the Cash Retainer Sub-Account of the Participant’s Account with respect to the deferral of cash retainer fees pursuant to Section 5 shall be made as of the dates the fees earned by the Participant during the applicable calendar year would otherwise have been payable to the Participant. The number of Deferred Stock Units to be credited shall be equal to the result of dividing the amount deferred as of each such date by the Fair Market Value of one share of Common Stock on such date.

(b) Restricted Stock Units. The crediting of Deferred Stock Units to the RSU Sub-Account of the Participant’s Account with respect to the deferral of Restricted Stock Units pursuant to Section 6 shall be made as of the dates the RSUs granted to the Participant during the applicable calendar year become vested. The number of Deferred Stock Units to be credited shall be equal to the number of RSUs that are deferred by the Participant as of such date.

(c) Cash Dividends. Whenever any cash dividends are declared on the Common Stock, the Company will credit the Cash Retainer and RSU Sub-Accounts of the Account of each Participant on the date such dividend is paid with a number of additional Deferred Stock Units equal to the result of dividing (i) the product of (x) the total number of Deferred Stock Units credited to the Participant’s Sub-Account on the record date for such dividend and (y) the per share amount of such dividend by (ii) the Fair Market Value of one share of Common Stock on the date such dividend is paid by the Company to the holders of Common Stock.

(d) Capitalization Adjustments. In the event of (i) any change in the Common Stock through a merger, consolidation, reorganization, recapitalization or otherwise, (ii) a stock dividend, or (iii) a stock split, combination or other changes the Common Stock, all as described in Section 5.7 of the Stock Plan, the Deferred Stock Units credited to the Cash Retainer and RSU Sub-Accounts of the Account of each Participant shall be increased or decreased proportionately in accordance with such Section.

8. Payment of Account. Payment of the Cash Retainer and RSU Sub-Accounts of the Participant’s Account shall be made in a lump sum to the Participant (or, in the event of the Participant’s death, to the Participant’s beneficiary, as provided in Section 10) in shares of Common Stock equal to the number of Deferred Stock Units credited to each Sub-Account (provided that any fractional Deferred Stock Units shall be paid in cash based on the Fair Market Value of one share of Common Stock on the payment date), as provided below.

 

3


(a) Cash Retainer Sub-Account. The Cash Retainer Sub-Account shall be paid, as elected by the Participant, on the tenth business day of January of the calendar year following:

(i) The earlier of the fourth anniversary of each date the applicable Deferred Stock Units were credited to the Sub-Account and the Participant’s termination of service as a Director for any reason;

(ii) The later of the fourth anniversary of each date the applicable Deferred Stock Units were credited to the Sub-Account and the Participant’s termination of service as a Director for any reason.

In the absence of an effective election, payment shall be made in accordance with sub-paragraph (ii) above.

(b) RSU Sub-Account. The RSU Sub-Account shall be paid on the tenth business day of January of the calendar year following the calendar year in which the Participant terminates service as a Director for any reason.

(c) Disabled Participant. Notwithstanding the provisions of subsections (a) and (b) of this Section 8, if a Participant is determined to be Disabled, then such Participant’s Account shall be paid on the tenth business day of January of the calendar year following the calendar year in which the Participant is determined to be Disabled. The determination of whether the Participant is Disabled shall be made by the Committee (excluding any member of the Committee who is the subject of such determination), which, in its discretion, may engage or consult a licensed practicing physician or other party as it deems appropriate.

9. Change of Control. In the event of a Change of Control (as defined in the Stock Plan) that constitutes a change in the ownership or effective control of the Company or in the ownership of a substantial portion of the Company’s assets under Section 409A, the Account of each Participant shall be paid to the Participant in a lump sum in cash within five business days after the date of the Change of Control, in an amount equal to the result of multiplying (i) the number of Deferred Stock Units credited to the Participant’s Account on the Change of Control date by (ii) the Fair Market Value of one share of Common Stock on the Change of Control date.

10. Beneficiary Designation. Each Participant shall have the right, at any time, to designate any person or persons as his beneficiary or beneficiaries to whom payment under the Plan shall be paid in the event of his or her death prior to payment to the Participant of his or her Account. Any beneficiary designation may be made or changed by a Participant by a written instrument, in such form prescribed by the Committee, which is filed with the Company prior to the Participant’s death. If a Participant fails to designate a beneficiary, or if all designated beneficiaries predecease the Participant, the Account shall be paid to the Participant’s estate.

11. Amendment and Termination. The Board may amend or terminate the Plan at any time in whole or in part; provided, however, that no amendment or termination shall reduce the Deferred Stock Units credited to a Participant’s Account or adversely affect the rights of a Participant to such Deferred Stock Units, without the consent of the Participant (or the Participant’s beneficiary in the event of the Participant’s death). Notwithstanding the foregoing, the Plan may be amended at any time, without the consent of any Participant (or beneficiary) if necessary or desirable to comply with the requirements, or avoid the application, of Section 409A.

 

4


12. General Provisions

(a) Unfunded Plan. The Company’s obligation to make payment under the Plan shall be contractual only and all payments hereunder shall be made by the Company from its general assets at the time and in the manner provided for in the Plan. No funds, securities or other property of any nature shall be segregated or earmarked for any current or former Participant, beneficiary or other person, and his or her sole right is as a general creditor of the Company with an unsecured claim against its general assets.

(b) Non-Alienation of Benefits. Neither a Participant nor any other person shall have any rights to sell, assign, transfer, pledge, anticipate, or otherwise encumber the amounts, if any, payable under the Plan to the Participant or any other person. Any attempted sale, assignment, transfer or pledge shall be null and void and without any legal effect. No part of the amounts payable under the Plan shall be subject to seizure or sequestration for the payment of any debts, judgments, alimony or separate maintenance owed by a Participant or any other person, nor be transferable by operation of law in the event of a Participant’s or any other person’s bankruptcy or insolvency.

(c) Section 409A. Notwithstanding any provision of the Plan to the contrary, the Plan will be construed, administered or deemed amended as necessary to comply with the requirements of Section 409A to avoid taxation under section 409A to the extent Section 409A applies to the Plan. The Committee, in its sole discretion shall determine the requirements of Section 409A that are applicable to the Plan and shall interpret the terms of the Plan in a manner consistent therewith. Under no circumstances, however, shall the Company or any affiliate or any of its or their employees, officers, directors, service providers or agents have any liability to any person for any taxes, penalties or interest due on amounts paid or payable under the Plan, including any taxes, penalties or interest imposed under Section 409A.

(d) No Stockholder Rights. Neither the Participant nor any other person shall have any rights as a stockholder of the Company with respect to the Deferred Stock Units credited to the Participant’s Account until the shares of Common Stock are issued to the Participant (or the beneficiary of the Participant).

(e) Severability. If any provision of the Plan shall be held illegal or invalid for any reason, such illegality or invalidity shall not affect the remaining provisions of the Plan, and the Plan shall be enforced as if the invalid provisions had never been set forth therein.

(f) Successors in Interest. The obligation of the Company under the Plan shall be binding upon any successor or successors of the Company, whether by merger, consolidation, sale of assets or otherwise, and for this purpose reference herein to the Company shall be deemed to include any such successor or successors.

(g) Governing Law; Interpretation. The Plan shall be construed and enforced in accordance with, and governed by, the laws of the State of Delaware, without giving effect to principles of conflict of laws.

 

5


Dates Referenced Herein

This ‘10-Q’ Filing    Date    Other Filings
Filed on:8/9/13None on these Dates
For Period end:6/30/13
1/1/11
12/23/10
 List all Filings 


3 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 4/29/22  Veradigm Inc.                     10-K/A     12/31/21   12:4M                                     Donnelley … Solutions/FA
 2/25/22  Veradigm Inc.                     10-K       12/31/21  150:28M                                    Donnelley … Solutions/FA
 2/26/21  Veradigm Inc.                     10-K       12/31/20  165:35M                                    ActiveDisclosure/FA
Top
Filing Submission 0001193125-13-329137   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sun., Apr. 28, 7:06:28.1am ET